The national law firm of Parker Waichman LLP continues to file lawsuits against Takeda over the type 2 diabetes drug Actos. The latest lawsuit was filed by the firm on behalf of a plaintiff from Tennessee who allegedly developed bladder cancer after using Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited, and Eli Lilly and Co. The complaint was filed in U.S. District Court for the Western District of Louisiana, where it joins hundreds of other lawsuits in multidistrict litigation.
According to the lawsuit, the plaintiff took Actos from 2002 to 2011, and developed bladder cancer in December 2004. The plaintiff says that Takeda knew or should have known of the significantly increased risks of bladder cancer when Actos is used for a year or longer, and that the company failed to warn the public about these risks. The plaintiff says that because of that failure to warn, patients have been unnecessarily exposed to bladder cancer.
The lawsuit seeks compensation for severe mental and physical pain and suffering, past and future permanent injuries and emotional distress, economic loss due to medical expenses and living related expenses as a result of a new lifestyle. The lawsuit also seeks compensation on behalf of the plaintiff’s wife for loss of consortium.